1. Home
  2. VALN vs EZPW Comparison

VALN vs EZPW Comparison

Compare VALN & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • EZPW
  • Stock Information
  • Founded
  • VALN 2012
  • EZPW 1989
  • Country
  • VALN France
  • EZPW United States
  • Employees
  • VALN N/A
  • EZPW N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • EZPW Other Specialty Stores
  • Sector
  • VALN Health Care
  • EZPW Consumer Discretionary
  • Exchange
  • VALN Nasdaq
  • EZPW Nasdaq
  • Market Cap
  • VALN 989.8M
  • EZPW 814.0M
  • IPO Year
  • VALN 2021
  • EZPW 1991
  • Fundamental
  • Price
  • VALN $8.63
  • EZPW $16.65
  • Analyst Decision
  • VALN Strong Buy
  • EZPW Strong Buy
  • Analyst Count
  • VALN 4
  • EZPW 3
  • Target Price
  • VALN $16.00
  • EZPW $19.33
  • AVG Volume (30 Days)
  • VALN 153.6K
  • EZPW 617.9K
  • Earning Date
  • VALN 08-12-2025
  • EZPW 07-30-2025
  • Dividend Yield
  • VALN N/A
  • EZPW N/A
  • EPS Growth
  • VALN N/A
  • EZPW 23.23
  • EPS
  • VALN N/A
  • EZPW 1.29
  • Revenue
  • VALN $230,566,060.00
  • EZPW $1,232,018,000.00
  • Revenue This Year
  • VALN $15.55
  • EZPW $9.93
  • Revenue Next Year
  • VALN $23.93
  • EZPW $6.42
  • P/E Ratio
  • VALN N/A
  • EZPW $12.95
  • Revenue Growth
  • VALN 25.47
  • EZPW 8.31
  • 52 Week Low
  • VALN $3.62
  • EZPW $10.56
  • 52 Week High
  • VALN $12.25
  • EZPW $16.80
  • Technical
  • Relative Strength Index (RSI)
  • VALN 46.03
  • EZPW 71.00
  • Support Level
  • VALN $8.71
  • EZPW $15.42
  • Resistance Level
  • VALN $9.05
  • EZPW $16.66
  • Average True Range (ATR)
  • VALN 0.46
  • EZPW 0.34
  • MACD
  • VALN -0.38
  • EZPW 0.03
  • Stochastic Oscillator
  • VALN 13.63
  • EZPW 89.13

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

Share on Social Networks: